SenzaGen’s Newsletter Q4 2025
Click image to view the Newsletter in browser. Text version: SenzaGen Newsletter Q4, 2025 As 2025 draws to a close: This quarter caps a year of significant progress in advancing […]
This author has not written his bio yet.
But we are proud to say that Julia Li contributed 73 entries already.
Click image to view the Newsletter in browser. Text version: SenzaGen Newsletter Q4, 2025 As 2025 draws to a close: This quarter caps a year of significant progress in advancing […]
Click image to view the Newsletter in browser. Safe dose levels for sensitizers, NESIL values for HRIPT, and PoD-based QRA Skin sensitization potency assessment has been in the spotlight at […]
Supporting industry decision-making and hypoallergenicity claims using an experimental setup combining GARD®skin Medical Device and Dose-Response protocols. Presented at 2025 Eurotox Download a copy in PDF Conclusion This case […]
In vitro skin sensitization potency assessment using GARD®skin Dose-Response: A case study on natural extracts-based skin-binding dyes and dye precursors Presented at 2025 Eurotox Download a copy in PDF […]
Comparative analysis of skin sensitization thresholds for Essential Oils: Human, murine, and GARD®skin Dose-Response Presented at 2025 Eurotox Download a copy in PDF Conclusion NESIL predictions from GARD® were […]
Click image to view the Newsletter in browser. SenzaGen Newsletter 2025 Q2 GARD®skin is now included in OECD TG 497 We are excited to announce that the GARDskin assay (OECD TG […]
NICEATM’s report confirms the inclusion of GARDskin improved the overall performance of the Defined Approaches for Skin Sensitization (DASS) The recent published report by NICEATM* summarizes an evaluation of the […]
Click image to view the Newsletter in browser. Text-only version: Scientific highlights from SOT 2025 SOT 2025 in Orlando was a fantastic opportunity to connect with industry leaders and present the […]
Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions
© SenzaGen 2026
